Khiron Life Sciences Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Khiron Life Sciences
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
Recent updates
Khiron Life Sciences Corp. (CVE:KHRN) Stock's 47% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 17
We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Khiron Life Sciences Corp.'s (CVE:KHRN) CEO For Now
Jun 24We're Keeping An Eye On Khiron Life Sciences' (CVE:KHRN) Cash Burn Rate
May 03What Type Of Returns Would Khiron Life Sciences'(CVE:KHRN) Shareholders Have Earned If They Purchased Their SharesYear Ago?
Feb 06In this section we usually analyse Khiron Life Sciences's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Khiron Life Sciences has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if KHRN.H's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if KHRN.H's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate KHRN.H's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if KHRN.H's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if KHRN.H's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if KHRN.H's interest payments on its debt are well covered by EBIT.